Figure 1From: Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia Relative contributions of the skeletal and extraskeletal effects of raloxifene. The total expected effectiveness is the sum of the contributions from the reduced incidence of vertebral fractures and breast cancers minus the QALYs lost from the increased incidence of venous thromboembolism. Abbreviations: QALY, quality-adjusted life year.Back to article page